Viewing Study NCT05271292


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-05-29 @ 1:02 AM
Study NCT ID: NCT05271292
Status: RECRUITING
Last Update Posted: 2024-07-16
First Post: 2022-01-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
Sponsor: Chipscreen Biosciences, Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small Cell Lung Cancer View
None Advanced Solid Malignant Tumor View
Keywords: